Patent ID: 8425934
Filing Date: 2013-04-23
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising: {1S-[1α,2α,3β(1S*,2R*),5β]}-3-(7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol as the active ingredient; and further comprising: a filler consisting essentially of a mixture of mannitol and dibasic calcium phosphate dihydrate; a binder consisting essentially of hydroxypropyl cellulose; a disintegrant consisting essentially of sodium starch glycolate; and one or more lubricants.